Is polycystic ovarian syndrome and insulin resistance associated with abnormal uterine bleeding in adolescents?

Ginekol Pol. 2019;90(5):262-269. doi: 10.5603/GP.2019.0049.

Abstract

Objectives: The aim of the study was to determine if adolescents with juvenile bleeding had polycystic ovarian syndrome (PCOS) and insulin resistance.

Material and methods: The study was conducted in a group of 43 females aged 12-18 years, diagnosed with juvenile menorrhagia, and 37 healthy female adolescents aged 12-18 years. The study was conducted during the early follicular phase of the menstrual cycle. Menstrual cycle disturbances, acne and hirsutism were recorded. Ultrasound scan determining the condition of the ovaries was conducted. Laboratory tests of the glucose level, cholesterol, LDL and HDL cholesterol and triglycerides fraction, DHEAS, FSH, LH, insulin, SHGB, total testosterone, androstenedione, and free testosterone have been established.

Results: The occurrence of regular menstrual cycles (30.23%, p = 0.006) was significantly lower in the juvenile bleeding group. Also, secondary amenorrhea was significantly more likely to be recognized in this group of females (p = 0.03). The concentration of FSH was considerably lower (p = 0.0002) in the group of adolescents with AUB.

Conclusions: Adolescents with abnormal uterine bleeding (AUB) are often diagnosed with secondary amenorrhea, and PCOS. The group with a diagnosis of juvenile bleeding was also diagnosed with higher rates of insulin resistance.

Keywords: abnormal uterine bleeding; hyperandrogenism; insulin resistance; polycystic ovarian syndrome.

MeSH terms

  • Adolescent
  • Case-Control Studies
  • Child
  • Female
  • Hormones / blood
  • Humans
  • Hyperandrogenism / complications
  • Hyperandrogenism / diagnostic imaging
  • Hyperandrogenism / epidemiology
  • Insulin Resistance / physiology*
  • Menorrhagia* / complications
  • Menorrhagia* / diagnostic imaging
  • Menorrhagia* / epidemiology
  • Pelvis / diagnostic imaging
  • Polycystic Ovary Syndrome* / complications
  • Polycystic Ovary Syndrome* / diagnostic imaging
  • Polycystic Ovary Syndrome* / epidemiology
  • Risk Factors
  • Ultrasonography

Substances

  • Hormones